logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

5 Micro and Small-Cap Biotechs Developing Stem Cell Treatments

By  +Follow August 1, 2013 8:43AM
Share:
Tickers Mentioned:

Stem cells have once again flitted through the news cycle, this time as a result of a new and growing industry that has arisen around the use of adult stem cells in cosmetic treatments that purport to both be more effective and less dangerous than traditional procedures such as the infamous and potentially toxic Botox injections.

But the scientific basis for the use of stem cells for cosmetic procedures is entirely tentative. To date, the US Food and Drug Administration has not approved any stem cell-based products for use, aside from a small number of umbilical cord blood-derived treatments for blood cancer as well as hereditary metabolic and autoimmune disorders.

Cosmetic treatments of any variety are subject to far less scrutiny than medical treatments, however, and this is what is currently allowing an increasing amount of doctors throughout the country to charge as much as $30,000 for procedures whose value are more or less unproven from the standpoint of official studies, clinical trials, and peer reviews.

Considering that so few medical products involving stem cells have been approved, a high degree of skepticism should probably be applied to any magical claims about the potential for stem cells to make one look younger, or to otherwise repair one’s perceived cosmetic iniquities. A terrifying article that appeared last December in The Scientific American suffices to support this contention.

But stem cells, whether of the adult of cord-blood variety, are believed to have regenerative properties that could repair all manner of human diseases and conditions, from cardiovascular conditions, to autoimmune diseases. The following five companies are biotechs that are working to ostensibly better the human condition through the use of stem-cell technology, and are all in the midst of clinical trials for various treatments, or on their way to beginning them

Osiris Therapeutics (OSIR) — With a market cap of $377 million, the Columbia, Maryland-based Osiris Therapeutics focuses on the development and marketing of stem cell products to treat serious inflammatory, autoimmune, orthopedic, and cardiovascular conditions. The company’s shares are currently priced at $11.45 and are up over 38 percent over the last six months.

Pluristem (PSTI) — The Israel-based Pluristem develops stem cell therapies from placenta cells for a number of diseases, and is currently preparing for clinical trials for a Peripheral Artery Disease treatment. The company has a market cap of $173.9 million, with shares trading at $2.98, down 7 percent over the past half year.

Cytori Therapeutics (CYTX) — Cytoris Therapeutics uses adult stem cells to develop regenerative therapies for cardiovascular conditions and soft tissue defects. The US company has a market cap of $188.9 million with shares currently priced at $2.82, up 2.5 percent over the last six months.

Neostem (NBS) — The New York, NY-based Neostem owns and operates a number of subsidiaries in the stem-cell based regenerative medicine industry that develop treatments for cardiovascular, autoimmune, and inflammatory conditions. The company is nearing clinical trials for a periodontitis treatment. With a market cap of $117.7 million, shares are currently priced at $7.05, up 10 percent over the past six months, and 17 percent year-to-date.

Advanced Cell Technology ($ACTC) — The Santa Monica, CA-based Advanced Cell Technology uses both adult and embryonic stem cells to develop treatments for retinal, blood, and heart diseases, and has recently initiated two different clinical trials for degenerative retinal disease. With a market cap of $179 million, shares are currently priced at $0.07, down $0.01 over the past six months.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for cytx
Trader News Daily
23 Nov 14 16:40:59
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $SFY $GST $HOV $JRJC $ISCO $CYTX
Trader News Daily
23 Nov 14 12:28:42
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $SFY $GST $HOV $JRJC $ISCO $CYTX
Greg David
23 Nov 14 06:28:50
I want to give http://t.co/m2LNLuLe8I a shout out. Banked 125% last week thanks to them. You guys rock! $NTRR $CYTX $EXEL $WPRT
Trader News Daily
23 Nov 14 03:35:51
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $SFY $GST $HOV $JRJC $ISCO $CYTX
PennyStockSuperstar
22 Nov 14 23:46:06
Check out our alert track record here... http://t.co/BdiZMRYWH1. Sign up is free. See you soon! $FNFG $SVU $CYTX $MM $PDS
Trader News Daily
22 Nov 14 19:45:23
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $SFY $GST $HOV $JRJC $ISCO $CYTX
ChartReaderE
22 Nov 14 15:19:28
$CYTX 📈 reminds me of (CHTP) chart ➕ keep in mind (CYTX) 📈 is good for making sharp moves to the upside...♦️♣️♥️♠️✌️...
Mark Trader
22 Nov 14 15:18:17
Thank you http://t.co/FOdvsRfk32! Your 5 pro traders are amazing. I would recommend the 14-day trial to anyone. $NTRR $CYTX $EXEL $WPRT
Mark Trader
22 Nov 14 10:24:53
Thank you http://t.co/FOdvsRfk32! Your 5 pro traders are amazing. I would recommend the 14-day trial to anyone. $NTRR $CYTX $EXEL $WPRT
4-traders.com
22 Nov 14 06:20:11
Cytori Therapeutics : Issues Cell Therapy Data http://t.co/xunkslEtY3 $CYTX
Greg David
22 Nov 14 06:17:35
I want to give http://t.co/m2LNLuLe8I a shout out. Banked 125% last week thanks to them. You guys rock! $NTRR $CYTX $EXEL $WPRT
Mark Trader
21 Nov 14 21:53:39
Thank you http://t.co/FOdvsRfk32! Your 5 pro traders are amazing. I would recommend the 14-day trial to anyone. $NTRR $CYTX $EXEL $WPRT
Greg David
21 Nov 14 17:25:16
I want to give http://t.co/m2LNLuLe8I a shout out. Banked 125% last week thanks to them. You guys rock! $NTRR $CYTX $EXEL $WPRT
Nasty Nick
21 Nov 14 16:05:00
@austinaucoin2 $CYTX short sellers are all over this. ACL study was good news. Gotta think this will fly when they cover.
MAISA
21 Nov 14 15:53:47
$CYTX released encouraging results from a clinical study of its Cytori Cell Therapy in anterior cruciate ligament, or ACL
C.Star
21 Nov 14 13:09:22
$CYTX Splendid close!!
12Stocks.com
21 Nov 14 13:01:30
Smallcap #Stocks Performance $NGVC $EIGI $GERN $GALE $FWM $BNFT $CYTX $PGNX $KEG $MDW $PSUN $EDMC $NEON more@ http://t.co/GiravokQod
Vincent
21 Nov 14 12:33:52
$CYTX wow, that was a big block
Vincent
21 Nov 14 11:53:50
$CYTX alerts at 0.42 and 0.47, no posn
Joshua Emberlin
21 Nov 14 11:23:06
RT @CraigCStrope: @zerosum24 Lemme get this straight. $CYTX beat estimates by $.05, positive results from 2 separate trials and is still un…
Urbane_Gorilla
21 Nov 14 11:22:26
RT @CraigCStrope: @zerosum24 Lemme get this straight. $CYTX beat estimates by $.05, positive results from 2 separate trials and is still un…
PhD_in_Patriotology
21 Nov 14 09:28:59
@zerosum24 Lemme get this straight. $CYTX beat estimates by $.05, positive results from 2 separate trials and is still under $1.00??
Mark Trader
21 Nov 14 09:17:26
Thank you http://t.co/FOdvsRfk32! Your 5 pro traders are amazing. I would recommend the 14-day trial to anyone. $NTRR $CYTX $EXEL $WPRT
Greg David
21 Nov 14 08:53:02
I want to give http://t.co/m2LNLuLe8I a shout out. Banked 125% last week thanks to them. You guys rock! $NTRR $CYTX $EXEL $WPRT
Damien Contarino
21 Nov 14 08:49:39
RT @BioBreakthrough: $CYTX rock bottom of chart, recent insider buying, multiple catalysts on the horizon. Prime Jan effect candidate.
DailyStockPicks
21 Nov 14 07:58:00
Cynapsus Therapeutics $CYNAF $CTH.V is up 40% this week after Phase 2 Study results. $2.75 target http://t.co/5Vy1M3qBcv $KOOL $CYTX $CLDX
Bryon Franzen
21 Nov 14 07:56:33
stem cells ... we know how this turns out .. GRAMMY $cytx http://t.co/oPhqXIv5fJ
PennyStockSuperstar
21 Nov 14 07:32:29
Check out our alert track record here... http://t.co/BdiZMRYWH1. Sign up is free. See you soon! $FNFG $SVU $CYTX $MM $PDS
avo
21 Nov 14 07:20:33
RT @BioBreakthrough: $CYTX rock bottom of chart, recent insider buying, multiple catalysts on the horizon. Prime Jan effect candidate.
Briefing.com
21 Nov 14 07:14:06
$CYTX: Cytori Therapeutics reported positive results from a clinical study of Cytori Cell Therapy in anterior... http://t.co/VckeyX0q4M
Exposethebest
21 Nov 14 07:12:21
TrendVestor: $CYTX had some news. http://t.co/2bWNOu2OWe
HotStockAlert $PKGM$
21 Nov 14 07:12:05
TrendVestor: $CYTX had some news. http://t.co/nWoyyv40Ne
Quantheta
21 Nov 14 07:00:05
#SENTISHIFTUP $AKAM $TNA $CAT $GE $CELG $GSK $CYTX $DIA $EBAY $SLV #quantheta #sentiquant
OTPicks.com
21 Nov 14 06:33:45
http://t.co/WZ6FGvJQNb ListenToMe: $CYTX soaring in premkt! NEWS out!!!: ListenToMe http://t.co/zS19o5Y5Zh http://t.co/WZ6FGvJQNb
OTPicks- OnTimePicks
21 Nov 14 06:33:43
http://t.co/f15mUdD9Cd ListenToMe: $CYTX soaring in premkt! NEWS out!!!: ListenToMe http://t.co/FkXo5BdbtU http://t.co/f15mUdD9Cd
OTPicks.com
21 Nov 14 06:33:36
http://t.co/y0P0rwqW7P ListenToMe: $CYTX soaring in premkt! NEWS out!!!: ListenToMe http://t.co/aMaaDLuZG3 http://t.co/y0P0rwqW7P
cintrix26
21 Nov 14 06:33:34
$CYTX Cytori Therapeutics reported positive results from a clinical study
O T P i c k s . com
21 Nov 14 06:33:29
http://t.co/x5EzijWmSl ListenToMe: $CYTX soaring in premkt! NEWS out!!!: ListenToMe http://t.co/fUzHUEMKgx http://t.co/x5EzijWmSl
Bryon Franzen
21 Nov 14 06:18:59
RT @Urbane_Gorilla: Insiders bought 280,000 shares of $CYTX last week between 0.38 and 0.40 : http://t.co/jKQB7evEOp
The Fly
21 Nov 14 06:17:16
On The Fly: Pre-market Movers $SPLK $FL $ROST $ADSK $CYTX $BID $ICLD $GALE $SCTY $WMT $OREX $ACAD $TRN $ARUN ... http://t.co/XewxkQpz5w
Bryon Franzen
21 Nov 14 06:15:42
$cytx looking for 50 cents today
Cytori Therapeutics
21 Nov 14 06:01:44
RT @CytoriIR: Cytori invites investors to live interactive webcast on 12/4 - More info here: http://t.co/SmdPWh7rzr $CYTX
J.D. Rogers
21 Nov 14 05:59:51
#gappers... $CYTX, $SPLK, $ICLD, $GALE, $MAGS, $RPI, $BGI, $BAMM, $CJJD, $AUPH, $EDAP, $JNUG, $HABT... http://t.co/dHfgCIkBK2
Cytori IR
21 Nov 14 05:57:47
Cytori invites investors to live interactive webcast on 12/4 - More info here: http://t.co/SmdPWh7rzr $CYTX
Cytori Therapeutics
21 Nov 14 05:56:53
Cytori Announces Promising Results in a Feasibility Trial of Cytori Cell Therapy in Conjunction with ACL Repair http://t.co/pFrnZauWs0 $CYTX
Cytori IR
21 Nov 14 05:56:53
Cytori Announces Promising Results in a Feasibility Trial of Cytori Cell Therapy in Conjunction with ACL Repair http://t.co/OaySdUQ4ji $CYTX
MarkBagger
21 Nov 14 05:44:44
CYTX, .46 gapping on news: Officers have been buying recently. Cytori Announces Promising Results in a Feasi $CYTX http://t.co/U0CjntTT4V
MarkBagger
21 Nov 14 05:44:09
CYTX, .46 gapping on news: Cytori Announces Promising Results in a Feasibility Trial of Cytori Cell Therapy i $CYTX http://t.co/ETSXLw8U1Y
BsiflingTrades
21 Nov 14 05:33:10
$CYTX reports promising results in Feasibility trial of Cytori Cell Therapy in ACL surgery ... off bottom .45 offered from chat.. should go
momotrader
21 Nov 14 05:31:15
good day to release news for $CYTX (0.45 in premkt) nothing earth shattering but should see bid volume today in this tape.
				
				
By  +Follow August 1, 2013 8:43AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.